ZFP36 loss-mediated BARX1 stabilization promotes malignant phenotypes by transactivating master oncogenes in NSCLC
Abstract Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, with high morbidity and mortality worldwide. Although the dysregulation of BARX1 expression has been shown to be associated with malignant cancers, including NSCLC, the underlying mechanism remains elusive. In this s...
Main Authors: | Tongjia Zhang, Lizhen Qiu, Jiashun Cao, Qiu Li, Lifan Zhang, Guoshun An, Juhua Ni, Hongti Jia, Shuyan Li, Kailong Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2023-08-01
|
Series: | Cell Death and Disease |
Online Access: | https://doi.org/10.1038/s41419-023-06044-z |
Similar Items
-
EGFR transactivates RON to drive oncogenic crosstalk
by: Carolina Franco Nitta, et al.
Published: (2021-11-01) -
ZFP36L2 Role in Thyroid Functionality
by: Francesco Albano, et al.
Published: (2021-08-01) -
Pancancer analysis of oncogenic BARX2 identifying its prognostic value and immunological function in liver hepatocellular carcinoma
by: Shian Yu, et al.
Published: (2023-05-01) -
The RNA binding proteins ZFP36L1 and ZFP36L2 are dysregulated in airway epithelium in human and a murine model of asthma
by: Jennifer Rynne, et al.
Published: (2023-10-01) -
ZFP36-mediated mRNA decay regulates metabolism
by: Andrew C. Cicchetto, et al.
Published: (2023-05-01)